Special items: Ovarian Cancer and Us blog best viewed in Firefox

Friday, July 29, 2011

MolMed starts a randomised Phase II trial of NGR-hTNF in ovarian cancer (financial news) - + prior trial results

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.